GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shockwave Medical Inc (NAS:SWAV) » Definitions » Price-to-Owner-Earnings

Shockwave Medical (Shockwave Medical) Price-to-Owner-Earnings : 108.61 (As of May. 01, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shockwave Medical Price-to-Owner-Earnings?

As of today (2024-05-01), Shockwave Medical's share price is $330.17. Shockwave Medical's Owner Earnings per Share (TTM) ended in Dec. 2023 was $3.04. It's Price-to-Owner-Earnings for today is 108.61.


The historical rank and industry rank for Shockwave Medical's Price-to-Owner-Earnings or its related term are showing as below:

SWAV' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 31.22   Med: 57.98   Max: 358.06
Current: 108.49

During the past 7 years, the highest Price-to-Owner-Earnings of Shockwave Medical was 358.06. The lowest was 31.22. And the median was 57.98.


SWAV's Price-to-Owner-Earnings is ranked worse than
85.14% of 276 companies
in the Medical Devices & Instruments industry
Industry Median: 33.815 vs SWAV: 108.49

As of today (2024-05-01), Shockwave Medical's share price is $330.17. Shockwave Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $3.87. Therefore, Shockwave Medical's PE Ratio for today is 85.32.

As of today (2024-05-01), Shockwave Medical's share price is $330.17. Shockwave Medical's EPS without NRI for the trailing twelve months (TTM) ended in was $3.87. Therefore, Shockwave Medical's PE Ratio without NRI for today is 85.32.

During the past 7 years, Shockwave Medical's highest PE Ratio without NRI was 278.55. The lowest was 25.08. And the median was 57.40.


Shockwave Medical Price-to-Owner-Earnings Historical Data

The historical data trend for Shockwave Medical's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shockwave Medical Price-to-Owner-Earnings Chart

Shockwave Medical Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial - - - 50.61 62.73

Shockwave Medical Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 50.61 45.64 58.05 38.61 62.73

Competitive Comparison of Shockwave Medical's Price-to-Owner-Earnings

For the Medical Devices subindustry, Shockwave Medical's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shockwave Medical's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shockwave Medical's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Shockwave Medical's Price-to-Owner-Earnings falls into.



Shockwave Medical Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Shockwave Medical's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=330.17/3.04
=108.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shockwave Medical  (NAS:SWAV) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Shockwave Medical Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Shockwave Medical's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Shockwave Medical (Shockwave Medical) Business Description

Traded in Other Exchanges
Address
5403 Betsy Ross Drive, Santa Clara, CA, USA, 95054
ShockWave Medical Inc is a medical device company focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Its intravascular lithotripsy technology is used in the treatment of calcified plaque. Geographically, the company generates its revenue from the United States, Europe and other countries.
Executives
Douglas Evan Godshall director, officer: President & CEO SUITE 4 LEVEL 46 2 PARK STREET, SIDNEY C3 2000
Frank T Watkins director 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Isaac Zacharias officer: Chief Commercial Officer 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Dan Puckett officer: CFO & Secretary 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Trinh Phung officer: VP, Finance C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Laura Francis director C/O SI-BONE, INC., 471 EL CAMINO REAL, SUITE 101, SANTA CLARA CA 95050
Sara Toyloy director C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Kevin J. Ballinger director C/O BOSTON SCIENTIFIC CORPORATION, 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA 01752-1234
Maria Sainz director C/O ORTHOFIX INTERNATIONAL N. V., 3451 PLANO PARKWAY, LEWISVILLE TX 75056
Antoine Papiernik director, 10 percent owner 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Sofinnova Capital Vii Fcpr 10 percent owner C/O SOFINNOVA PARTNERS, 18 RUE DU 4 SEPTEMBRE, 75002 PARIS I0 00000
Cahill Colin director 5403 BETSY ROSS DRIVE, SANTA CLARA CA 95054
Frederic H Moll director C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
James E Flynn 10 percent owner, other: Possible Member of 10% Group 780 THIRD AVENUE, 37TH FLOOR, NEW YORK NY 10017
Larkin C Raymond Jr director C/O MALLINCKRODT INC, 7733 FORSYTH BLVD, ST LOUIS MO 63105